FEBURIC
Live / Applied — Fifth extension granted (statement of use) (as of 09 Dec 2025)
What this means for you
Not registered yet, but its 12 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97407235
- Mark type
- Stylized text
- Filed
- 12 May 2022
- Published for opposition
- 18 Apr 2023
- Attorney of record
- LEIGH ANN LINDQUIST
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hyperuric and gout
Owner
- Teijin Pharma Limited, Tokyo, JP
- Teijin Pharma Limited, Tokyo, JP
Prosecution history
- 10 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Dec 2025 — SOU EXTENSION 5 GRANTED
- 25 Nov 2025 — SOU EXTENSION 5 FILED
- 25 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 16 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 May 2025 — SOU EXTENSION 4 GRANTED
- 15 May 2025 — SOU EXTENSION 4 FILED
- 15 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Feb 2025 — SOU EXTENSION 3 GRANTED
- 18 Nov 2024 — SOU EXTENSION 3 FILED
- 03 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 15 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 May 2024 — SOU EXTENSION 2 GRANTED